Diagnosing allergies with Skin Prick Automated Test (S.P.A.T.)

Not Applicable

Completed

• Conditions: Allergy diagnostics; Not Applicable

• Registration Number: ISRCTN14098475
• Lead Sponsor: Hippo DX

Brief Summary

2022 Results article in https://doi.org/10.1111/all.15619 (added 02/06/2023) 2023 Results article in https://pubmed.ncbi.nlm.nih.gov/38026131/ (added 05/08/2024)

Detailed Description

Not available

Study Timeline

• Study Completion: 2022-05-31
• Study Start: 2022-07-18
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 118

Inclusion Criteria

Aged between 18 and 65 years old

Exclusion Criteria

1. Skin pathologies like chronic or exuberant urticaria, dermographism, and chronic dermatitis that need daily treatment
2. Use of antihistaminic medication < 7 days before the start of the study
3. Use of tricyclic antidepressants (antihistamine activity) < 7 days before the start of the study
4. Use of topical corticoids on the forearm < 7 days before the start of the study
5. Use of omalizumab < 6 months before the start of the study
6. Pregnancy

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Coefficient of variation wheal size (mm) measured using manual skin prick test (SPT) and SPAT at 15 minutes after skin prick

Secondary Outcome Measures

Name	Time	Method
umber of true positive and true negative wheals using manual skin prick test (SPT) and SPAT at 15 minutes after skin prick